Clinical trials: Evaluate Two Paradigms for Simultaneous Assessment of Hepatic and Intestinal CYP3A

Evaluate Two Paradigms for Simultaneous Assessment of Hepatic and Intestinal CYP3A

Alfentanil: Simultaneous Testing Pilot

• Completed
• Age: 18 to 40 years
• Results posted

To evaluate two paradigms for simultaneous assessment of hepatic and intestinal CYP3A activity.

Trial name

NCT01008059

Testing

Alfentanil

Where

United States

Volunteers

6 people, healthy volunteers welcome

Sponsor

Washington University School of Medicine